Latest financial market updates and expert analysis
Analysis Biotechnology firm MacroGenics is executing a strategic pivot, redirecting its resources after discontinuing a major clinical trial arm. The company’s focus is now squarely on advancing its alternative oncology programs...
The strategic competition within the critical minerals sector has entered a new phase. China Northern Rare Earth Group, a state-owned...
Monday finds Ethereum caught between significant technical progress and skittish investor sentiment. The asset’s price is hovering perilously close to...
Applovin (APP) enters a pivotal week for its stock, with quarterly results set to determine whether a severe recent sell-off...
Recent regulatory filings reveal a clear divergence in how major investors are positioning themselves in Procter & Gamble (P&G) stock....
IO Biotech finds itself at a pivotal juncture following a significant clinical trial disappointment. The company’s lead therapeutic candidate has...
Shares of the U.S. energy behemoth Chevron are trading near record highs, buoyed by investor enthusiasm for an unexpected strategic...
A definitive judicial ruling has now paved the way for Coeur Mining to finalize one of North America’s most significant...
Alibaba is intensifying its commitment to artificial intelligence, a strategic shift that has captured the attention of investors weighing the...
For income-focused investors, Realty Income Corporation continues to demonstrate its core value proposition: dependable monthly distributions. This commitment is underscored...
Investors in D-Wave Quantum Inc. are on a rollercoaster ride, with the stock exhibiting extreme volatility driven by a major...
